Report date: Apr 30, 2024 Conflict count: 350192 Publisher: SAGE Publications Title count: 528 Conflict count: 29357 ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189524 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Massaro, 4 ,1,1,1998,Cerebrospinal fluid markers in multiple sclerosis: an overview DOI: 10.1191/135245898678909196(Journal) (5189524-N ) DOI: 10.1177/135245859800400101(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189525 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Thompson, 4 ,1,5,1998,Protein markers of brain damage DOI: 10.1191/135245898678909169(Journal) (5189525-N ) DOI: 10.1177/135245859800400102(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189526 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sivieri, 4 ,1,7,1998,Multiple Sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls DOI: 10.1191/135245898678909150(Journal) (5189526-N ) DOI: 10.1177/135245859800400103(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189527 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Link, 4 ,1,12,1998,The cytokine storm in multiple sclerosis DOI: 10.1191/135245898678909141(Journal) (5189527-N ) DOI: 10.1177/135245859800400104(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189528 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Whitaker, 4 ,1,16,1998,Myelin basic protein in cerebrospinal fluid and other body fluids DOI: 10.1191/135245898678909123(Journal) (5189528-N ) DOI: 10.1177/135245859800400105(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189530 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Frederiksen, 4 ,1,22,1998,Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI DOI: 10.1191/135245898678909213(Journal) (5189530-N ) DOI: 10.1177/135245859800400106(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189532 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Giovannoni, 4 ,1,27,1998,Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis DOI: 10.1191/135245898678909178(Journal) (5189532-N ) DOI: 10.1177/135245859800400107(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189534 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Cortese, 4 ,1,31,1998,Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients DOI: 10.1191/135245898678909132(Journal) (5189534-N ) DOI: 10.1177/135245859800400108(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189536 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lamers, 4 ,1,37,1998,Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines DOI: 10.1191/135245898678909187(Journal) (5189536-N ) DOI: 10.1177/135245859800400109(Journal) ========================================================== Created: 2017-01-15 04:54:12.0 ConfID: 5189537 CauseID: 1400567941 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Trojano, 4 ,1,39,1998,Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system DOI: 10.1191/135245898678909204(Journal) (5189537-N ) DOI: 10.1177/135245859800400110(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189813 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Stoner, 4 ,2,45,1998,JC virus excreted by multiple sclerosis patients and paired controls from Hungary DOI: 10.1191/135245898678919564(Journal) (5189813-N ) DOI: 10.1177/135245859800400201(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189814 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Ferrante, 4 ,2,49,1998,Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients DOI: 10.1191/135245898678919528(Journal) (5189814-N ) DOI: 10.1177/135245859800400202(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189815 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Mews, 4 ,2,55,1998,Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions DOI: 10.1191/135245898678919582(Journal) (5189815-N ) DOI: 10.1177/135245859800400203(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189816 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Khan, 4 ,2,63,1998,Immunomodulating functions of recombinant ovine interferon tau: potential for therapy in mulitple sclerosis and autoimmune disorders DOI: 10.1191/135245898678919573(Journal) (5189816-N ) DOI: 10.1177/135245859800400204(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189817 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Gaines, 4 ,2,70,1998,Interferon beta-1b injection site reactions and necroses DOI: 10.1191/135245898678919546(Journal) (5189817-N ) DOI: 10.1177/135245859800400205(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189818 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Dubois, 4 ,2,74,1998,Toxicity in a double-blind, placebo-controlled pilot trial with D-penicillamine and metacycline in secondary progressive multiple sclerosis DOI: 10.1191/135245898678919537(Journal) (5189818-N ) DOI: 10.1177/135245859800400206(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189819 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Accornero, 4 ,2,79,1998,Computerized color perimetry in multiple sclerosis DOI: 10.1191/135245898678919555(Journal) (5189819-N ) DOI: 10.1177/135245859800400207(Journal) ========================================================== Created: 2017-01-15 04:58:00.0 ConfID: 5189820 CauseID: 1400568950 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rossiter, 4 ,2,85,1998,Integrated care pathways in multiple sclerosis rehabilitation: completing the audit cycle DOI: 10.1191/135245898678919519(Journal) (5189820-N ) DOI: 10.1177/135245859800400208(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189838 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Huang, 6 ,2,61,2000,Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis DOI: 10.1191/135245800678827509(Journal) (5189838-N ) DOI: 10.1177/135245850000600201(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189839 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Hay, 6 ,2,66,2000,Leukotropic herpesviruses in multiple sclerosis DOI: 10.1191/135245800678827527(Journal) (5189839-N ) DOI: 10.1177/135245850000600202(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189840 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rohowsky-Kochan, 6 ,2,69,2000,Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis DOI: 10.1191/135245800678827554(Journal) (5189840-N ) DOI: 10.1177/135245850000600203(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189841 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Kremenchutzky, 6 ,2,81,2000,Diagnostic brain MRI findings in primary progressive multiple sclerosis DOI: 10.1191/135245800678827608(Journal) (5189841-N ) DOI: 10.1177/135245850000600205(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189842 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Grima, 6 ,2,91,2000,Cost and health related quality of life consequences of multiple sclerosis DOI: 10.1191/135245800678827545(Journal) (5189842-N ) DOI: 10.1177/135245850000600207(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189843 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Tan, 6 ,2,99,2000,Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials DOI: 10.1191/135245800678827626(Journal) (5189843-N ) DOI: 10.1177/135245850000600208(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189844 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Nielsen, 6 ,2,105,2000,Baclofen increases the soleus stretch reflex threshold in the early swing phase during walking in spastic multiple sclerosis patients DOI: 10.1191/135245800678827518(Journal) (5189844-N ) DOI: 10.1177/135245850000600209(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189845 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Patten, 6 ,2,115,2000,Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population DOI: 10.1191/135245800678827536(Journal) (5189845-N ) DOI: 10.1177/135245850000600210(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189846 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Broadley, 6 ,2,121,2000,Multiple sclerosis and tonsillectomy: no evidence for an influence on the development of disease or clinical phenotype DOI: 10.1191/135245800678827581(Journal) (5189846-N ) DOI: 10.1177/135245850000600211(Journal) ========================================================== Created: 2017-01-15 04:58:30.0 ConfID: 5189847 CauseID: 1400569170 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Kroencke, 6 ,2,131,2000,Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern DOI: 10.1191/135245800678827590(Journal) (5189847-N ) DOI: 10.1177/135245850000600213(Journal) ========================================================== Created: 2017-01-15 04:59:14.0 ConfID: 5189871 CauseID: 1400569317 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Filippi, 4 ,6,469,1998,Newer magnetic resonance techniques and disease activity in multiple sclerosis: new concepts and new concerns DOI: 10.1191/135245898678845142(Journal) (5189871-N ) DOI: 10.1177/135245859800400601(Journal) ========================================================== Created: 2017-01-15 04:59:14.0 ConfID: 5189872 CauseID: 1400569317 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Filippi, 4 ,6,471,1998,The effect of cross-talk on MRI lesion numbers and volumes in multiple sclerosis using conventional and turbo spin-echo DOI: 10.1191/135245898678845188(Journal) (5189872-N ) DOI: 10.1177/135245859800400602(Journal) ========================================================== Created: 2017-01-15 04:59:14.0 ConfID: 5189873 CauseID: 1400569317 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sellebjerg, 4 ,6,475,1998,Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis DOI: 10.1191/135245898678845151(Journal) (5189873-N ) DOI: 10.1177/135245859800400603(Journal) ========================================================== Created: 2017-01-15 04:59:14.0 ConfID: 5189874 CauseID: 1400569317 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Goodkin, 4 ,6,480,1998,Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials DOI: 10.1191/135245898678845179(Journal) (5189874-N ) DOI: 10.1177/135245859800400604(Journal) ========================================================== Created: 2017-01-15 04:59:14.0 ConfID: 5189875 CauseID: 1400569317 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Ablashi, 4 ,6,490,1998,Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report DOI: 10.1191/135245898678845133(Journal) (5189875-N ) DOI: 10.1177/135245859800400606(Journal) ========================================================== Created: 2017-01-15 05:00:52.0 ConfID: 5189916 CauseID: 1400569752 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Iriarte, 5 ,1,10,1999,The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis DOI: 10.1191/135245899701564263(Journal) (5189916-N ) DOI: 10.1177/135245859900500103(Journal) ========================================================== Created: 2017-01-15 05:00:52.0 ConfID: 5189917 CauseID: 1400569752 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Karussis, 5 ,1,17,1999,Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation DOI: 10.1191/135245899701564272(Journal) (5189917-N ) DOI: 10.1177/135245859900500104(Journal) ========================================================== Created: 2017-01-15 05:00:52.0 ConfID: 5189918 CauseID: 1400569752 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Liu, 5 ,1,22,1999,Assessing relapses in treatment trials of relapsing and remitting multiple sclerosis: can we do better? DOI: 10.1191/135245899701564281(Journal) (5189918-N ) DOI: 10.1177/135245859900500105(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189919 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bashir, 6 ,5,312,2000,Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI DOI: 10.1191/135245800678827987(Journal) (5189919-N ) DOI: 10.1177/135245850000600503(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189920 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Kalanie, 6 ,5,317,2000,Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran DOI: 10.1191/135245800678827950(Journal) (5189920-N ) DOI: 10.1177/135245850000600504(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189921 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Filippi, 6 ,5,320,2000,Enhanced magnetic resonance imaging in multiple sclerosis DOI: 10.1191/135245800678827969(Journal) (5189921-N ) DOI: 10.1177/135245850000600505(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189922 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Griffin, 6 ,5,327,2000,MTR and T1 provide complementary information in MS NAWM, but not in lesions DOI: 10.1191/135245800678827941(Journal) (5189922-N ) DOI: 10.1177/135245850000600506(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189923 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Luks, 6 ,5,332,2000,A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis DOI: 10.1191/135245800678827905(Journal) (5189923-N ) DOI: 10.1177/135245850000600507(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189924 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Feinstein, 6 ,5,343,2000,Multiple sclerosis, disease modifying treatments and depression: a critical methodological review DOI: 10.1191/135245800678828012(Journal) (5189924-N ) DOI: 10.1177/135245850000600509(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189925 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Gottberg, 6 ,5,349,2000,Interferon-beta treatment for patients with multiple sclerosis: the patients'' perceptions of the side-effects DOI: 10.1191/135245800678827978(Journal) (5189925-N ) DOI: 10.1177/135245850000600510(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189926 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Cohen, 6 ,5,355,2000,MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment DOI: 10.1191/135245800678827897(Journal) (5189926-N ) DOI: 10.1177/135245850000600511(Journal) ========================================================== Created: 2017-01-15 05:00:54.0 ConfID: 5189927 CauseID: 1400569753 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Constantinescu, 6 ,5,362,2000,Long term azathioprine fails to prevent onset of multiple sclerosis: report of two cases DOI: 10.1191/135245800678827996(Journal) (5189927-N ) DOI: 10.1177/135245850000600512(Journal) ========================================================== Created: 2017-01-15 05:01:17.0 ConfID: 5189929 CauseID: 1400569827 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Micera, 5 ,6,389,1999,Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis DOI: 10.1191/135245899678846474(Journal) (5189929-N ) DOI: 10.1177/135245859900500i604(Journal) ========================================================== Created: 2017-01-15 05:01:17.0 ConfID: 5189931 CauseID: 1400569827 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Karussis, 5 ,6,395,1999,Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature DOI: 10.1191/135245899678846429(Journal) (5189931-N ) DOI: 10.1177/135245859900500i605(Journal) ========================================================== Created: 2017-01-15 05:01:17.0 ConfID: 5189935 CauseID: 1400569827 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: null, 5 ,6,432,1999,Acknowledgement to Referees DOI: 10.1191/135245899678846519(Journal) (5189935-N ) DOI: 10.1177/135245859900500i611(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189973 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rudick, 6 ,6,365,2000,Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1a DOI: 10.1191/135245800701566322(Journal) (5189973-N ) DOI: 10.1177/135245850000600601(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189974 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Fisher, 6 ,6,373,2000,Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients DOI: 10.1191/135245800701566331(Journal) (5189974-N ) DOI: 10.1177/135245850000600602(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189975 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Constantinescu, 6 ,6,378,2000,Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis DOI: 10.1191/135245800701566340(Journal) (5189975-N ) DOI: 10.1177/135245850000600603(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189976 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Balcer, 6 ,6,382,2000,Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25) DOI: 10.1191/135245800701566359(Journal) (5189976-N ) DOI: 10.1177/135245850000600604(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189977 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Zorzon, 6 ,6,386,2000,Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study DOI: 10.1191/135245800701566368(Journal) (5189977-N ) DOI: 10.1177/135245850000600605(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189978 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Benedict, 6 ,6,391,2000,Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients DOI: 10.1191/135245800701566377(Journal) (5189978-N ) DOI: 10.1177/135245850000600606(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189979 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rätsep, 6 ,6,397,2000,Personality as a predictor of coping efforts in patients with multiple sclerosis DOI: 10.1191/135245800701566386(Journal) (5189979-N ) DOI: 10.1177/135245850000600607(Journal) ========================================================== Created: 2017-01-15 05:02:30.0 ConfID: 5189980 CauseID: 1400570219 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Hillman, 6 ,6,403,2000,Neurological worsening due to infection from renal stones in a multiple sclerosis patient DOI: 10.1191/135245800701566395(Journal) (5189980-N ) DOI: 10.1177/135245850000600608(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5189996 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Silver, 7 ,2,75,2001,Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study DOI: 10.1191/135245801678227577(Journal) (5189996-N ) DOI: 10.1177/135245850100700201(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5189997 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Werring, 7 ,2,83,2001,Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions DOI: 10.1191/135245801678227586(Journal) (5189997-N ) DOI: 10.1177/135245850100700202(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5189998 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rasmussen, 7 ,2,91,2001,Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis DOI: 10.1191/135245801678227595(Journal) (5189998-N ) DOI: 10.1177/135245850100700203(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5189999 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Huang, 7 ,2,95,2001,Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression DOI: 10.1191/135245801678227603(Journal) (5189999-N ) DOI: 10.1177/135245850100700204(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5190000 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Di Marco, 7 ,2,101,2001,Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat DOI: 10.1191/135245801678227612(Journal) (5190000-N ) DOI: 10.1177/135245850100700205(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5190001 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Albrecht, 7 ,2,105,2001,Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter DOI: 10.1191/135245801678227621(Journal) (5190001-N ) DOI: 10.1177/135245850100700206(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5190002 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: McDonnell, 7 ,2,111,2001,An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study DOI: 10.1191/135245801678227630(Journal) (5190002-N ) DOI: 10.1177/135245850100700207(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5190003 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Gold, 7 ,2,119,2001,Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS) DOI: 10.1191/135245801678227649(Journal) (5190003-N ) DOI: 10.1177/135245850100700208(Journal) ========================================================== Created: 2017-01-15 05:02:54.0 ConfID: 5190004 CauseID: 1400570294 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bethoux, 7 ,2,137,2001,Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life DOI: 10.1191/135245801678227667(Journal) (5190004-N ) DOI: 10.1177/135245850100700210(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190056 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Silberberg, 7 ,1,1,2001,Millennium Reflections DOI: 10.1191/135245801674920661(Journal) (5190056-N ) DOI: 10.1177/135245850100700101(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190058 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: The Transatlantic Multiple Sclerosis Genetics Cooperative, 7 ,1,3,2001,A meta-analysis of genomic screens in multiple sclerosis DOI: 10.1191/135245801669625359(Journal) (5190058-N ) DOI: 10.1177/135245850100700102(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190061 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Krametter, 7 ,1,13,2001,Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker DOI: 10.1191/135245801676514804(Journal) (5190061-N ) DOI: 10.1177/135245850100700103(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190063 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Gasperini, 7 ,1,27,2001,Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis DOI: 10.1191/135245801672817145(Journal) (5190063-N ) DOI: 10.1177/135245850100700106(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190067 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Wolinsky, 7 ,1,33,2001,United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates DOI: 10.1191/135245801667520627(Journal) (5190067-N ) DOI: 10.1177/135245850100700107(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190068 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Ragheb, 7 ,1,43,2001,Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells DOI: 10.1191/135245801674411026(Journal) (5190068-N ) DOI: 10.1177/135245850100700108(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190070 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Richert, 7 ,1,49,2001,Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis DOI: 10.1191/135245801669116174(Journal) (5190070-N ) DOI: 10.1177/135245850100700109(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190075 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Myhr, 7 ,1,59,2001,Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension DOI: 10.1191/135245801667968135(Journal) (5190075-N ) DOI: 10.1177/135245850100700110(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190077 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: de Assis Aquino Gondim, 7 ,1,67,2001,Episodic hyperlibidinism in multiple sclerosis DOI: 10.1191/135245801674860127(Journal) (5190077-N ) DOI: 10.1177/135245850100700111(Journal) ========================================================== Created: 2017-01-15 05:04:21.0 ConfID: 5190078 CauseID: 1400570676 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Crawley, 7 ,1,71,2001,Acute pulmonary oedema: presenting symptom of multiple sclerosis DOI: 10.1191/135245801669565077(Journal) (5190078-N ) DOI: 10.1177/135245850100700112(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190129 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Feinstein, 5 ,2,69,1999,Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex DOI: 10.1191/135245899678847248(Journal) (5190129-N ) DOI: 10.1177/135245859900500201(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190130 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Fulton, 5 ,2,74,1999,Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals DOI: 10.1191/135245899678847284(Journal) (5190130-N ) DOI: 10.1177/135245859900500202(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190131 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Goodin, 5 ,2,78,1999,Survey of multiple sclerosis in Northern California DOI: 10.1191/135245899678847257(Journal) (5190131-N ) DOI: 10.1177/135245859900500203(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190132 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Kroencke, 5 ,2,89,1999,Stress and coping in multiple sclerosis: exacerbation, remission and chronic subgroups DOI: 10.1191/135245899678847266(Journal) (5190132-N ) DOI: 10.1177/135245859900500204(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190133 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Langdon, 5 ,2,94,1999,Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome DOI: 10.1191/135245899678847220(Journal) (5190133-N ) DOI: 10.1177/135245859900500205(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190134 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Matusevicius, 5 ,2,101,1999,Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis DOI: 10.1191/135245899678847275(Journal) (5190134-N ) DOI: 10.1177/135245859900500206(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190135 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Smith, 5 ,2,110,1999,Recent developments in drug therapy for multiple sclerosis DOI: 10.1191/135245899678847239(Journal) (5190135-N ) DOI: 10.1177/135245859900500208(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190136 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Spadaro, 5 ,2,121,1999,Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies DOI: 10.1191/135245899678847211(Journal) (5190136-N ) DOI: 10.1177/135245859900500209(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190137 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Yoshikawa, 5 ,2,126,1999,Effects of phosphodiesterase inhibitors on cytokine production by microglia DOI: 10.1191/135245899678847194(Journal) (5190137-N ) DOI: 10.1177/135245859900500210(Journal) ========================================================== Created: 2017-01-15 05:05:42.0 ConfID: 5190138 CauseID: 1400570946 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Zouali, 5 ,2,134,1999,Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis DOI: 10.1191/135245899678847202(Journal) (5190138-N ) DOI: 10.1177/135245859900500211(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190215 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lassmann, 4 ,3,93,1998,Neuropathology in multiple sclerosis: new concepts DOI: 10.1191/135245898678909367(Journal) (5190215-N ) DOI: 10.1177/135245859800400301(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190216 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Jongen, 4 ,3,108,1998,Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis DOI: 10.1191/135245898678909330(Journal) (5190216-N ) DOI: 10.1177/135245859800400303(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190217 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Reiber, 4 ,3,111,1998,The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis DOI: 10.1191/135245898678909448(Journal) (5190217-N ) DOI: 10.1177/135245859800400304(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190218 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Cortese, 4 ,3,118,1998,CSF-enriched antibodies do not share specificities among MS patients DOI: 10.1191/135245898678909268(Journal) (5190218-N ) DOI: 10.1177/135245859800400305(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190219 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lamers, 4 ,3,124,1998,Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis DOI: 10.1191/135245898678909358(Journal) (5190219-N ) DOI: 10.1177/135245859800400306(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190220 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sellebjerg, 4 ,3,127,1998,MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis DOI: 10.1191/135245898678909475(Journal) (5190220-N ) DOI: 10.1177/135245859800400307(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190221 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Frederiksen, 4 ,3,132,1998,Can CSF predict the course of optic neuritis? DOI: 10.1191/135245898678909295(Journal) (5190221-N ) DOI: 10.1177/135245859800400308(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190222 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Wekerle, 4 ,3,136,1998,Immune pathogenesis of multiple sclerosis. Brain autoimmune reactivity and its control by neuronal function DOI: 10.1191/135245898678909547(Journal) (5190222-N ) DOI: 10.1177/135245859800400309(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190223 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Giovannoni, 4 ,3,138,1998,Are there any body fluid markers of brain atrophy in multiple sclerosis? DOI: 10.1191/135245898678909303(Journal) (5190223-N ) DOI: 10.1177/135245859800400310(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190224 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Monteyne, 4 ,3,143,1998,Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR DOI: 10.1191/135245898678909420(Journal) (5190224-N ) DOI: 10.1177/135245859800400311(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190225 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Laman, 4 ,3,147,1998,Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide DOI: 10.1191/135245898678909349(Journal) (5190225-N ) DOI: 10.1177/135245859800400312(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190226 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Reder, 4 ,3,162,1998,Monocyte activation in multiple sclerosis DOI: 10.1191/135245898678909538(Journal) (5190226-N ) DOI: 10.1177/135245859800400314(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190227 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sharief, 4 ,3,169,1998,Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination? DOI: 10.1191/135245898678909484(Journal) (5190227-N ) DOI: 10.1177/135245859800400315(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190228 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rieckmann, 4 ,3,178,1998,Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis DOI: 10.1191/135245898678909457(Journal) (5190228-N ) DOI: 10.1177/135245859800400317(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190229 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Trojano, 4 ,3,183,1998,Serum soluble intercellular adhesion molecule-1 in MS: relation to clinical and Gd-MRI activity and to rIFNβ-1b treatment DOI: 10.1191/135245898678909510(Journal) (5190229-N ) DOI: 10.1177/135245859800400318(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190230 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Chofflon, 4 ,3,188,1998,Monitoring Multiple Sclerosis course and activity with TNF-alpha DOI: 10.1191/135245898678909231(Journal) (5190230-N ) DOI: 10.1177/135245859800400319(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190231 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Debruyne, 4 ,3,193,1998,Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations? DOI: 10.1191/135245898678909277(Journal) (5190231-N ) DOI: 10.1177/135245859800400320(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190232 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Schluep, 4 ,3,198,1998,In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis DOI: 10.1191/135245898678909466(Journal) (5190232-N ) DOI: 10.1177/135245859800400321(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190233 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Stinissen, 4 ,3,203,1998,Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis DOI: 10.1191/135245898678909493(Journal) (5190233-N ) DOI: 10.1177/135245859800400322(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190234 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Giovannoni, 4 ,3,212,1998,The potential role of nitric oxide in multiple sclerosis DOI: 10.1191/135245898678909312(Journal) (5190234-N ) DOI: 10.1177/135245859800400323(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190235 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Asakura, 4 ,3,217,1998,A unique population of circulating autoantibodies promotes central nervous system remyelination DOI: 10.1191/135245898678909222(Journal) (5190235-N ) DOI: 10.1177/135245859800400324(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190236 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Massaro, 4 ,3,228,1998,Are there indicators of remyelination in blood or CSF of multiple sclerosis patients? DOI: 10.1191/135245898678909402(Journal) (5190236-N ) DOI: 10.1177/135245859800400326(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190237 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Coles, 4 ,3,232,1998,Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapy DOI: 10.1191/135245898678909240(Journal) (5190237-N ) DOI: 10.1177/135245859800400327(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190238 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Luján, 4 ,3,239,1998,The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment DOI: 10.1191/135245898678909394(Journal) (5190238-N ) DOI: 10.1177/135245859800400328(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190239 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Whitaker, 4 ,3,243,1998,Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and neuroimaging changes DOI: 10.1191/135245898678909529(Journal) (5190239-N ) DOI: 10.1177/135245859800400329(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190240 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Giovannoni, 4 ,3,247,1998,Urinary markers of disease activity in multiple sclerosis DOI: 10.1191/135245898678909321(Journal) (5190240-N ) DOI: 10.1177/135245859800400330(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190241 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Mehta, 4 ,3,254,1998,Free light chains in multiple sclerosis urine DOI: 10.1191/135245898678909411(Journal) (5190241-N ) DOI: 10.1177/135245859800400331(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190242 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Thompson, 4 ,3,257,1998,Identification of brain atrophy with MRI in MS DOI: 10.1191/135245898678909501(Journal) (5190242-N ) DOI: 10.1177/135245859800400332(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190243 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Comi, 4 ,3,260,1998,Neurophysiological and cognitive markers of disease evolution in multiple sclerosis DOI: 10.1191/135245898678909259(Journal) (5190243-N ) DOI: 10.1177/135245859800400333(Journal) ========================================================== Created: 2017-01-15 05:08:56.0 ConfID: 5190244 CauseID: 1400571671 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Laman, 4 ,3,266,1998,Body fluid markers to monitor multiple sclerosis: the assays and the challenges DOI: 10.1191/135245898678909556(Journal) (5190244-N ) DOI: 10.1177/135245859800400334(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190249 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Leary, 5 ,5,313,1999,Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis DOI: 10.1191/135245899678846384(Journal) (5190249-N ) DOI: 10.1177/135245859900500502(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190250 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Nortvedt, 5 ,5,317,1999,Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a DOI: 10.1191/135245899678846339(Journal) (5190250-N ) DOI: 10.1177/135245859900500503(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190251 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Feinstein, 5 ,5,323,1999,The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis DOI: 10.1191/135245899678846348(Journal) (5190251-N ) DOI: 10.1177/135245859900500504(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190252 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rohowsky-Kochan, 5 ,5,327,1999,Impaired interleukin-12 production in multiple sclerosis patients DOI: 10.1191/135245899678846357(Journal) (5190252-N ) DOI: 10.1177/135245859900500505(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190253 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Giovannoni, 5 ,5,335,1999,Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease DOI: 10.1191/135245899678846320(Journal) (5190253-N ) DOI: 10.1177/135245859900500506(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190254 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Hohol, 5 ,5,349,1999,Disease steps in multiple sclerosis: a longitudinal study comparing Disease Steps and EDSS to evaluate disease progression DOI: 10.1191/135245899678846375(Journal) (5190254-N ) DOI: 10.1177/135245859900500508(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190255 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Friedman, 5 ,5,355,1999,The association of the human herpesvirus-6 and MS DOI: 10.1191/135245899678846311(Journal) (5190255-N ) DOI: 10.1177/135245859900500509(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190256 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Benedetti, 5 ,5,363,1999,Gait abnormalities in minimally impaired multiple sclerosis patients DOI: 10.1191/135245899678846393(Journal) (5190256-N ) DOI: 10.1177/135245859900500510(Journal) ========================================================== Created: 2017-01-15 05:09:14.0 ConfID: 5190257 CauseID: 1400571767 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Jacobs, 5 ,5,369,1999,A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium DOI: 10.1191/135245899678846302(Journal) (5190257-N ) DOI: 10.1177/135245859900500511(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190413 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Chen, 7 ,4,209,2001,Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS DOI: 10.1191/135245801680209303(Journal) (5190413-N ) DOI: 10.1177/135245850100700401(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190414 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sharma, 7 ,4,221,2001,Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging DOI: 10.1191/135245801680209312(Journal) (5190414-N ) DOI: 10.1177/135245850100700402(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190415 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sánchez, 7 ,4,227,2001,Clinical features of multiple sclerosis in a genetically homogeneous tropical population DOI: 10.1191/135245801680209321(Journal) (5190415-N ) DOI: 10.1177/135245850100700403(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190416 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Nortvedt, 7 ,4,231,2001,Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction DOI: 10.1191/135245801680209330(Journal) (5190416-N ) DOI: 10.1177/135245850100700404(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190417 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Kroencke, 7 ,4,237,2001,Depression during exacerbations in multiple sclerosis: the importance of uncertainty DOI: 10.1191/135245801680209349(Journal) (5190417-N ) DOI: 10.1177/135245850100700405(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190418 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Yang, 7 ,4,249,2001,Physiologic studies of male sexual dysfunction in multiple sclerosis DOI: 10.1191/135245801680209367(Journal) (5190418-N ) DOI: 10.1177/135245850100700407(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190419 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Boringa, 7 ,4,263,2001,The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice DOI: 10.1191/135245801680209385(Journal) (5190419-N ) DOI: 10.1177/135245850100700409(Journal) ========================================================== Created: 2017-01-15 05:11:51.0 ConfID: 5190420 CauseID: 1400572441 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Green, 7 ,4,269,2001,Multiple sclerosis and oligodendroglioma DOI: 10.1191/135245801680209394(Journal) (5190420-N ) DOI: 10.1177/135245850100700410(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190570 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Weinshenker, 5 ,4,206,1999,Databases in MS research: pitfalls and promises DOI: 10.1191/135245899678846096(Journal) (5190570-N ) DOI: 10.1177/135245859900500402(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190571 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Confavreux, 5 ,4,212,1999,Clinical progression and decision making process in multiple sclerosis DOI: 10.1191/135245899678846104(Journal) (5190571-N ) DOI: 10.1177/135245859900500403(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190572 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Amato, 5 ,4,216,1999,Quantification of impairment in MS: discussion of the scales in use DOI: 10.1191/135245899678846113(Journal) (5190572-N ) DOI: 10.1177/135245859900500404(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190573 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lienert, 5 ,4,220,1999,Use of composite scores in the quantification of deterioration in multiple sclerosis DOI: 10.1191/135245899678846122(Journal) (5190573-N ) DOI: 10.1177/135245859900500405(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190574 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sharrack, 5 ,4,223,1999,The Guy''s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis DOI: 10.1191/135245899678846131(Journal) (5190574-N ) DOI: 10.1177/135245859900500406(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190575 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Grimaud, 5 ,4,234,1999,Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED DOI: 10.1191/135245899678846140(Journal) (5190575-N ) DOI: 10.1177/135245859900500407(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190576 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Beatty, 5 ,4,239,1999,Assessment of cognitive and psychological functions in patients with multiple sclerosis: considerations for databasing DOI: 10.1191/135245899678846159(Journal) (5190576-N ) DOI: 10.1177/135245859900500408(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190577 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Fischer, 5 ,4,244,1999,The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment DOI: 10.1191/135245899678846168(Journal) (5190577-N ) DOI: 10.1177/135245859900500409(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190578 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Fischer, 5 ,4,251,1999,Recent developments in the assessment of quality of life in Multiple Sclerosis (MS) DOI: 10.1191/135245899678846177(Journal) (5190578-N ) DOI: 10.1177/135245859900500410(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190579 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Thompson, 5 ,4,260,1999,Measuring handicap in multiple sclerosis DOI: 10.1191/135245899678846186(Journal) (5190579-N ) DOI: 10.1177/135245859900500411(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190580 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Comi, 5 ,4,263,1999,Measuring evoked responses in multiple sclerosis DOI: 10.1191/135245899678846195(Journal) (5190580-N ) DOI: 10.1177/135245859900500412(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190581 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Stevenson, 5 ,4,268,1999,Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis DOI: 10.1191/135245899678846203(Journal) (5190581-N ) DOI: 10.1177/135245859900500413(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190582 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Filippi, 5 ,4,273,1999,Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques DOI: 10.1191/135245899678846212(Journal) (5190582-N ) DOI: 10.1177/135245859900500414(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190583 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Barkhof, 5 ,4,283,1999,MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) DOI: 10.1191/135245899678846221(Journal) (5190583-N ) DOI: 10.1177/135245859900500415(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190584 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lux, 5 ,4,291,1999,The revision of the international classification of impairments, disabilities and handicaps and its application in MS DOI: 10.1191/135245899678846249(Journal) (5190584-N ) DOI: 10.1177/135245859900500417(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190585 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Koch-Henriksen, 5 ,4,293,1999,The Danish Multiple Sclerosis Registry: a 50-year follow-up DOI: 10.1191/135245899678846258(Journal) (5190585-N ) DOI: 10.1177/135245859900500418(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190586 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Palace, 5 ,4,297,1999,The UK Multiple Sclerosis Database DOI: 10.1191/135245899678846267(Journal) (5190586-N ) DOI: 10.1177/135245859900500419(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190587 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: van Overstraten, 5 ,4,302,1999,The patient''s role in the improvement of care DOI: 10.1191/135245899678846285(Journal) (5190587-N ) DOI: 10.1177/135245859900500421(Journal) ========================================================== Created: 2017-01-15 05:14:32.0 ConfID: 5190588 CauseID: 1400573134 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: null, 5 ,4,306,1999,Nice Declaration DOI: 10.1191/135245899678846294(Journal) (5190588-N ) DOI: 10.1177/135245859900500422(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190806 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Allen, 5 ,3,137,1999,Editorial DOI: 10.1191/135245899678846078(Journal) (5190806-N ) DOI: 10.1177/135245859900500301(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190807 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bitsch, 5 ,3,138,1999,Lesion development in Marburg''s type of acute multiple sclerosis: from inflammation to demyelination DOI: 10.1191/135245899678845998(Journal) (5190807-N ) DOI: 10.1177/135245859900500302(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190808 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Schmidt, 5 ,3,147,1999,Candidate autoantigens in multiple sclerosis DOI: 10.1191/135245899678845989(Journal) (5190808-N ) DOI: 10.1177/135245859900500303(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190809 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Gareau, 5 ,3,161,1999,Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: Comparison of functional magnetic resonance imaging and visual evoked potentials DOI: 10.1191/135245899678846041(Journal) (5190809-N ) DOI: 10.1177/135245859900500304(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190810 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Armstrong, 5 ,3,165,1999,Relationship between tumour necrosis factor-alpha (TNFα) production and a specific multiple sclerosis (MS) associated TNF gene haplotype DOI: 10.1191/135245899678846023(Journal) (5190810-N ) DOI: 10.1177/135245859900500305(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190811 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lević, 5 ,3,171,1999,Prognostic factors for survival in multiple sclerosis DOI: 10.1191/135245899678846005(Journal) (5190811-N ) DOI: 10.1177/135245859900500306(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190812 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rae-Grant, 5 ,3,179,1999,Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity DOI: 10.1191/135245899678846032(Journal) (5190812-N ) DOI: 10.1177/135245859900500307(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190813 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Ishikawa, 5 ,3,184,1999,Nasal administration of transforming growth factor-β1 induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis DOI: 10.1191/135245899678846050(Journal) (5190813-N ) DOI: 10.1177/135245859900500308(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190814 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Mohr, 5 ,3,192,1999,Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis DOI: 10.1191/135245899678846069(Journal) (5190814-N ) DOI: 10.1177/135245859900500309(Journal) ========================================================== Created: 2017-01-15 05:19:32.0 ConfID: 5190815 CauseID: 1400574423 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rostami, 5 ,3,198,1999,A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis DOI: 10.1191/135245899678846014(Journal) (5190815-N ) DOI: 10.1177/135245859900500310(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190914 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Steinman, 7 ,5,275,2001,Blockade of gamma interferon might be beneficial in MS DOI: 10.1191/135245801681137951(Journal) (5190914-N ) DOI: 10.1177/135245850100700501(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190915 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Egg, 7 ,5,285,2001,Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis DOI: 10.1191/135245801681137979(Journal) (5190915-N ) DOI: 10.1177/135245850100700503(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190916 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Sormani, 7 ,5,298,2001,Modelling new enhancing MRI lesion counts in multiple sclerosis DOI: 10.1191/135245801681137997(Journal) (5190916-N ) DOI: 10.1177/135245850100700505(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190917 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Walker, 7 ,5,305,2001,Pirfenidone for chronic progressive multiple sclerosis DOI: 10.1191/135245801681138004(Journal) (5190917-N ) DOI: 10.1177/135245850100700506(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190919 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Spitsin, 7 ,5,313,2001,Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease DOI: 10.1191/135245801681138013(Journal) (5190919-N ) DOI: 10.1177/135245850100700507(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190920 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Merkelbach, 7 ,5,320,2001,Cardiovascular autonomic dysregulation and fatigue in multiple sclerosis DOI: 10.1191/135245801681138022(Journal) (5190920-N ) DOI: 10.1177/135245850100700508(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190922 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Flachenecker, 7 ,5,327,2001,Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability DOI: 10.1191/135245801681138031(Journal) (5190922-N ) DOI: 10.1177/135245850100700509(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190924 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Hoogervorst, 7 ,5,335,2001,Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis DOI: 10.1191/135245801681138040(Journal) (5190924-N ) DOI: 10.1177/135245850100700510(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190926 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Amato, 7 ,5,340,2001,Quality of life in multiple sclerosis: the impact of depression, fatigue and disability DOI: 10.1191/135245801681138059(Journal) (5190926-N ) DOI: 10.1177/135245850100700511(Journal) ========================================================== Created: 2017-01-15 05:20:52.0 ConfID: 5190927 CauseID: 1400574741 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Ramsaransing, 7 ,5,345,2001,Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review DOI: 10.1191/135245801681138068(Journal) (5190927-N ) DOI: 10.1177/135245850100700512(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191062 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Neuhaus, 7 ,3,143,2001,In search of a disease marker: the cytokine profile of primary progressive multiple sclerosis DOI: 10.1191/135245801678438348(Journal) (5191062-N ) DOI: 10.1177/135245850100700301(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191063 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Killestein, 7 ,3,145,2001,Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease DOI: 10.1191/135245801678438357(Journal) (5191063-N ) DOI: 10.1177/135245850100700302(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191064 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Durán, 7 ,3,151,2001,Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis DOI: 10.1191/135245801678438366(Journal) (5191064-N ) DOI: 10.1177/135245850100700303(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191065 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Dai, 7 ,3,157,2001,Analysis of an interferon-γ gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients DOI: 10.1191/135245801678438375(Journal) (5191065-N ) DOI: 10.1177/135245850100700304(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191066 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Spitsin, 7 ,3,165,2001,Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins DOI: 10.1191/135245801678438384(Journal) (5191066-N ) DOI: 10.1177/135245850100700305(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191067 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Morgen, 7 ,3,167,2001,Ring-enhancement in multiple sclerosis: marker of disease severity DOI: 10.1191/135245801678438393(Journal) (5191067-N ) DOI: 10.1177/135245850100700306(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191068 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: European Study Group on Interferon-Beta-1a in MS, 7 ,3,179,2001,Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX): rationale, design and baseline data DOI: 10.1191/135245801678438410(Journal) (5191068-N ) DOI: 10.1177/135245850100700308(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191069 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Khan, 7 ,3,185,2001,Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy DOI: 10.1191/135245801678438429(Journal) (5191069-N ) DOI: 10.1177/135245850100700309(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191070 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Buchanan, 7 ,3,189,2001,Profiles of nursing home residents with multiple sclerosis using the minimum data set DOI: 10.1191/135245801678438438(Journal) (5191070-N ) DOI: 10.1177/135245850100700310(Journal) ========================================================== Created: 2017-01-15 05:24:59.0 ConfID: 5191071 CauseID: 1400575879 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bowen, 7 ,3,201,2001,Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test DOI: 10.1191/135245801678438447(Journal) (5191071-N ) DOI: 10.1177/135245850100700311(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259004 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Tranquill, 6 ,4,220,2000,Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients DOI: 10.1191/135245800678827833(Journal) (5259004-N ) DOI: 10.1177/135245850000600402(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259005 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Blumhardt, 6 ,4,231,2000,A quality network model for the daily care of multiple sclerosis DOI: 10.1191/135245800678827842(Journal) (5259005-N ) DOI: 10.1177/135245850000600404(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259006 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Molyneux, 6 ,4,237,2000,The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study DOI: 10.1191/135245800678827798(Journal) (5259006-N ) DOI: 10.1177/135245850000600405(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259007 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Vleugels, 6 ,4,241,2000,Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks DOI: 10.1191/135245800678827879(Journal) (5259007-N ) DOI: 10.1177/135245850000600406(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259008 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Johnson, 6 ,4,255,2000,Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years DOI: 10.1191/135245800678827806(Journal) (5259008-N ) DOI: 10.1177/135245850000600407(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259009 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Miller, 6 ,4,267,2000,A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations DOI: 10.1191/135245800678827770(Journal) (5259009-N ) DOI: 10.1177/135245850000600408(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259010 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Carton, 6 ,4,274,2000,A quantitative study of unpaid caregiving in multiple sclerosis DOI: 10.1191/135245800678827789(Journal) (5259010-N ) DOI: 10.1177/135245850000600409(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259011 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lazeron, 6 ,4,280,2000,Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR DOI: 10.1191/135245800678827824(Journal) (5259011-N ) DOI: 10.1177/135245850000600410(Journal) ========================================================== Created: 2017-06-29 18:48:31.0 ConfID: 5259012 CauseID: 1408167666 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Kaufman, 6 ,4,286,2000,The significant change for the Timed 25-Foot Walk in the Multiple Sclerosis Functional Composite DOI: 10.1191/135245800678827860(Journal) (5259012-N ) DOI: 10.1177/135245850000600411(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259039 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Rossini, 7 ,6,354,2001,Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine DOI: 10.1191/135245801701567050(Journal) (5259039-N ) DOI: 10.1177/135245850100700602(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259040 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Tintoré, 7 ,6,359,2001,Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS DOI: 10.1191/135245801701567069(Journal) (5259040-N ) DOI: 10.1177/135245850100700603(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259041 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Cramer, 7 ,6,364,2001,Changes in motor cortex activation after recovery from spinal cord inflammation DOI: 10.1191/135245801701567078(Journal) (5259041-N ) DOI: 10.1177/135245850100700604(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259042 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Malcus-Vocanson, 7 ,6,383,2001,Glial toxicity in urine and multiple sclerosis DOI: 10.1191/135245801701567104(Journal) (5259042-N ) DOI: 10.1177/135245850100700607(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259043 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Vleugels, 7 ,6,389,2001,Visuoperceptual impairment in MS patients: nature and possible neural origins DOI: 10.1191/135245801701567113(Journal) (5259043-N ) DOI: 10.1177/135245850100700608(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259044 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Tüzün, 7 ,6,402,2001,Paroxysmal attacks in multiple sclerosis DOI: 10.1191/135245801701567122(Journal) (5259044-N ) DOI: 10.1177/135245850100700609(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259045 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Cheng, 7 ,6,405,2001,Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores DOI: 10.1191/135245801701566989(Journal) (5259045-N ) DOI: 10.1177/135245850100700610(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259046 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Lynch, 7 ,6,411,2001,The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope DOI: 10.1191/135245801701566998(Journal) (5259046-N ) DOI: 10.1177/135245850100700611(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259047 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Foley, 7 ,6,417,2001,Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis DOI: 10.1191/135245801701567005(Journal) (5259047-N ) DOI: 10.1177/135245850100700612(Journal) ========================================================== Created: 2017-06-29 18:53:37.0 ConfID: 5259048 CauseID: 1408168811 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: null, 7 ,6,426,2001,List of reviewers DOI: 10.1191/135245801701567032(Journal) (5259048-N ) DOI: 10.1177/135245850100700613(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259057 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Ciccarelli, 6 ,3,137,2000,Antinuclear antibodies and response to IFNβ-1a therapy in relapsing-remitting multiple sclerosis DOI: 10.1191/135245800701565981(Journal) (5259057-N ) DOI: 10.1177/135245850000600301(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259058 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Buhler, 6 ,3,140,2000,T cell receptor β chain genotyping in Australian relapsing-remitting multiple sclerosis patients DOI: 10.1191/135245800701565990(Journal) (5259058-N ) DOI: 10.1177/135245850000600302(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259059 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Berg, 6 ,3,156,2000,Lesion pattern in patients with multiple sclerosis and depression DOI: 10.1191/135245800701566016(Journal) (5259059-N ) DOI: 10.1177/135245850000600304(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259060 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Balcer, 6 ,3,163,2000,New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis DOI: 10.1191/135245800701566025(Journal) (5259060-N ) DOI: 10.1177/135245850000600305(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259061 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Koch-Henriksen, 6 ,3,172,2000,The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis DOI: 10.1191/135245800701566034(Journal) (5259061-N ) DOI: 10.1177/135245850000600306(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259062 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: White, 6 ,3,176,2000,Effect of precooling on physical performance in multiple sclerosis DOI: 10.1191/135245800701566043(Journal) (5259062-N ) DOI: 10.1177/135245850000600307(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259063 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bakshi, 6 ,3,181,2000,Fatigue in multiple sclerosis and its relationship to depression and neurologic disability DOI: 10.1191/135245800701566052(Journal) (5259063-N ) DOI: 10.1177/135245850000600308(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259064 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Feinstein, 6 ,3,186,2000,Confabulation and multiple sclerosis: a rare association DOI: 10.1191/135245800701566061(Journal) (5259064-N ) DOI: 10.1177/135245850000600309(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259065 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Solaro, 6 ,3,192,2000,Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis DOI: 10.1191/135245800701565927(Journal) (5259065-N ) DOI: 10.1177/135245850000600310(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259066 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: null, 6 ,3,198,2000,Oral Presentations DOI: 10.1191/135245800701565945(Journal) (5259066-N ) DOI: 10.1177/135245850000600312(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259067 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: null, 6 ,3,203,2000,Poster Presentations DOI: 10.1191/135245800701565954(Journal) (5259067-N ) DOI: 10.1177/135245850000600313(Journal) ========================================================== Created: 2017-06-29 18:58:20.0 ConfID: 5259068 CauseID: 1408169687 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: null, 6 ,3,210,2000,Non-Traditional Therapy DOI: 10.1191/135245800701565963(Journal) (5259068-N ) DOI: 10.1177/135245850000600314(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259071 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Koudriavtseva, 4 ,5,403,1998,Determinants of Gd-enhanced MRI response to IFN-β-1a treatment in relapsing-remitting multiple sclerosis DOI: 10.1191/135245898678919429(Journal) (5259071-N ) DOI: 10.1177/135245859800400501(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259072 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: O''Riordan, 4 ,5,408,1998,T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation DOI: 10.1191/135245898678919483(Journal) (5259072-N ) DOI: 10.1177/135245859800400502(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259073 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Vladimirova, 4 ,5,413,1998,Oxidative damage to DNA in plaques of MS brains DOI: 10.1191/135245898678919456(Journal) (5259073-N ) DOI: 10.1177/135245859800400503(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259074 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Whetten-Goldstein, 4 ,5,419,1998,A comprehensive assessment of the cost of multiple sclerosis in the United States DOI: 10.1191/135245898678919401(Journal) (5259074-N ) DOI: 10.1177/135245859800400504(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259075 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Schwartz, 4 ,5,426,1998,Patient perception of quality of care provided by specialists and generalists DOI: 10.1191/135245898678919410(Journal) (5259075-N ) DOI: 10.1177/135245859800400505(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259076 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Paul, 4 ,5,433,1998,Impairments of attention in individuals with Multiple Sclerosis DOI: 10.1191/135245898678919438(Journal) (5259076-N ) DOI: 10.1177/135245859800400506(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259077 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Beatty, 4 ,5,440,1998,Correlates of coping style in patients with multiple sclerosis DOI: 10.1191/135245898678919447(Journal) (5259077-N ) DOI: 10.1177/135245859800400507(Journal) ========================================================== Created: 2017-06-29 18:59:47.0 ConfID: 5259078 CauseID: 1408170003 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Goodin, 4 ,5,444,1998,A questionnaire to assess neurological impairment in multiple sclerosis DOI: 10.1191/135245898678919474(Journal) (5259078-N ) DOI: 10.1177/135245859800400508(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259484 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Silberberg, 6 ,1,1,2000,Millennium editorial DOI: 10.1191/135245800678827482(Journal) (5259484-N ) DOI: 10.1177/135245850000600101(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259485 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Marks, 6 ,1,2,2000,Publisher''s announcement DOI: 10.1191/135245800678827491(Journal) (5259485-N ) DOI: 10.1177/135245850000600102(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259486 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Zhang, 6 ,1,3,2000,Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis DOI: 10.1191/135245800678827446(Journal) (5259486-N ) DOI: 10.1177/135245850000600103(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259487 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Huang, 6 ,1,14,2000,Evaluation of the Apo-1/Fas promoter Mva I polymorphism in multiple sclerosis DOI: 10.1191/135245800678827392(Journal) (5259487-N ) DOI: 10.1177/135245850000600104(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259488 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Petereit, 6 ,1,19,2000,Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients DOI: 10.1191/135245800678827383(Journal) (5259488-N ) DOI: 10.1177/135245850000600105(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259489 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Adler, 6 ,1,24,2000,Positive association between blood brain barrier disruption and osmotically-induced demyelination DOI: 10.1191/135245800678827419(Journal) (5259489-N ) DOI: 10.1177/135245850000600106(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259490 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Weatherby, 6 ,1,32,2000,Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis DOI: 10.1191/135245800678827464(Journal) (5259490-N ) DOI: 10.1177/135245850000600107(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259491 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bartnik, 6 ,1,37,2000,Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress DOI: 10.1191/135245800678827400(Journal) (5259491-N ) DOI: 10.1177/135245850000600108(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259492 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Bagnato, 6 ,1,43,2000,Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study DOI: 10.1191/135245800678827437(Journal) (5259492-N ) DOI: 10.1177/135245850000600109(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259493 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Jeffery, 6 ,1,50,2000,Cortical deficits in multiple sclerosis on the basis of subcortical lesions DOI: 10.1191/135245800678827428(Journal) (5259493-N ) DOI: 10.1177/135245850000600110(Journal) ========================================================== Created: 2017-07-02 11:53:58.0 ConfID: 5259494 CauseID: 1408400622 OtherID: 14343277 JT: Multiple Sclerosis Journal MD: Suzumura, 6 ,1,56,2000,Drop in relapse rate of MS by combination therapy of three different phosphodiesterase inhibitors DOI: 10.1191/135245800678827455(Journal) (5259494-N ) DOI: 10.1177/135245850000600111(Journal)